Xenon Pharmaceuticals (XENE) Other Operating Expenses (2014 - 2026)
Xenon Pharmaceuticals (XENE) posted quarterly Other Operating Expenses of $76.5 million for Q1 2026, up 377.18% year-over-year from $16.0 million in Q1 2025, and up 175.74% quarter-over-quarter from -$101.0 million in Q4 2025.
Xenon Pharmaceuticals (XENE) Other Operating Expenses (2014 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Other Operating Expenses for 6 consecutive years, with $76.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses rose 377.18% year-over-year to $76.5 million; the TTM figure through Mar 2026 stood at -$61.4 million (up 85.07% YoY), while the FY2025 annual figure was -$119.3 million, down 14.89% from the prior year.
- Other Operating Expenses rose to $76.5 million in Q1 2026 per XENE's latest filing, from -$101.0 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $98.5 million in Q4 2022 and bottomed at -$229.8 million in Q4 2024.
- Historically, Other Operating Expenses has averaged -$37.9 million across 4 years, with a median of -$28.9 million in 2025.
- Annual changes were most pronounced in 2025 — Other Operating Expenses sank 463.42% — and 2026, when it soared 377.18%.
- Xenon Pharmaceuticals' Other Operating Expenses stood at $98.5 million in 2022, then slumped by 333.35% to -$229.8 million in 2024, then surged by 56.05% to -$101.0 million in 2025, then jumped by 175.74% to $76.5 million in 2026.
- Business Quant data shows XENE's Other Operating Expenses at $76.5 million in Q1 2026, -$101.0 million in Q4 2025, and -$6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Xenon Pharmaceuticals | 6.03 Bn | 6.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.03 Mn |
| Mar 31, 2026 | 76.51 Mn |
| Dec 31, 2025 | -101.02 Mn |
| Sep 30, 2025 | -6.72 Mn |
| Jun 30, 2025 | -30.18 Mn |
| Mar 31, 2025 | -27.60 Mn |
| Dec 31, 2024 | -229.84 Mn |
| Sep 30, 2024 | -78.79 Mn |
| Jun 30, 2024 | -75.11 Mn |
| Mar 31, 2024 | -4.90 Mn |
| Dec 31, 2022 | 98.49 Mn |
| Mar 31, 2018 | 4.40 Mn |
| Jun 30, 2014 | 141,000.00 |
| Mar 31, 2014 | 136,000.00 |